Arcturus Therapeutics (ARCT) – Analyst Ratings
-
Laidlaw Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
-
Canaccord Genuity Starts Arcturus Therapeutics (ARCT) at Buy
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ARCT Stock Lookup